Market Tracker

06/23 5:16pm ET

GenMark Diagnostics Inc (NASDAQ:GNMK)

12.75
Delayed Data
As of Jun 23
 +0.10 / +0.79%
Today’s Change
7.82
Today|||52-Week Range
13.67
+4.17%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close12.65
Today’s open12.65
Day’s range12.37 - 12.87
Volume555,592
Average volume (3 months)317,590
Market cap$681.7M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-15.00%
Earnings growth (this year)+15.94%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+25.03%
P/E ratioNM
Price/Sales10.95
Price/Book15.56

Competitors

 Today’s
change
Today’s
% change
CRYCryoLife Inc+0.30+1.53%
ANIKAnika Therapeutics I...+0.88+1.84%
ANGOAngioDynamics Inc+0.14+0.85%
LMATLeMaitre Vascular In...+0.79+2.69%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$49.3M
Annual profit (last year)-$50.6M
Net profit margin-102.69%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
CFO &
Principal Accounting Office
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts